Will β-blockers live up to the maxim of Sir James Black, their creator?

Angiology. 2012 Aug;63(6):409-11. doi: 10.1177/0003319711434636.
No abstract available

Publication types

  • Review

MeSH terms

  • Adrenergic beta-Antagonists / adverse effects*
  • Adrenergic beta-Antagonists / therapeutic use
  • Humans
  • Hypertension / drug therapy*
  • Incidence
  • Neoplasms* / chemically induced
  • Neoplasms* / epidemiology
  • Neoplasms* / pathology
  • Prognosis
  • Risk Factors

Substances

  • Adrenergic beta-Antagonists